Shares of Innoviva Inc. (INVA), a diversified holding company with a portfolio of royalties and other healthcare assets, have lost nearly 14% of their value year-to-date to trade around $11.
Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
By Raghav Mahobe and Sriparna Roy (Reuters) - A panel of U.S. Food and Drug Administration advisers on Monday unanimously voted in favor of Innoviva I.
By Raghav Mahobe and Sriparna Roy (Reuters) - A panel of U.S. Food and Drug Administration advisers on Monday unanimously voted in favor of Innoviva I.
The panel on Monday unanimously voted in favor of Innoviva s experimental antibiotic in the treatment of serious bacterial infections, typically associated with hospitalizations, the company said.